Entrada Therapeutics
Innovating to transform the treatment of serious diseases through establishing a new class of genetic medicines.
207 employees · est. 2016 · Boston, United States
Avadel Pharmaceuticals PLC is the older company (1990 vs 2016).
Side-by-Side Comparison
| Metric | Avadel Pharmaceuticals PLC | Entrada Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 1990 older | 2016 |
| Headquarters | ||
| Headquarters | Dublin, Ireland | Boston, United States |
| Employees | ||
| Employees | 216 | 207 |
| Industry | ||
| Industry | Biotechnology, Information Technology, Manufacturing | Biotechnology |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | Not tracked yet | $483.10M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 7 |
| Services | ||
| Services | Not tracked yet | Development of intracellular therapeutics, Clinical trials, Research on undruggable targets, Development of disease-specific therapies |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with neuromuscular disorders, Families affected by Duchenne Muscular Dystrophy, Researchers and medical professionals, Biotechnology investors |
| Taxonomy | ||
| Taxonomy | Not tracked yet | Intracellular Therapeutics, Genetic Medicines, Neuromuscular Diseases, Inherited Retinal Diseases, Oligonucleotide Programs, Duchenne Muscular Dystrophy, Exon Skipping, Myotonic Dystrophy Type 1, Clinical-stage Biopharmaceutical, Boston Seaport Community, Proprietary Approaches, Versatile And Modular Development, Biopharma Innovation, Disease Transformation |
| Website | ||
| Website | avadel.com | entradatx.com |
About Avadel Pharmaceuticals PLC
Avadel Pharmaceuticals PLC, a biopharmaceutical company listed on Nasdaq as AVDL, is dedicated to revolutionizing medicines for enhanced lives. The company's focus on disrupting conventions primarily targets narcolepsy, with a commitment to leveraging innovative solutions to develop medications that...
About Entrada Therapeutics
Entrada Therapeutics, founded in 2016, is a clinical-stage biopharmaceutical company based in Boston’s Seaport community. The company is committed to transforming therapeutic approaches for challenging diseases by focusing on intracellular targets previously deemed unreachable. With a mission encaps...
We will tell you when either one moves
BounceWatch watches Avadel Pharmaceuticals PLC and Entrada Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Avadel Pharmaceuticals... and Entrada Therapeutics — by email.
Frequently Asked Questions
Compare Avadel Pharmaceuticals PLC with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Entrada Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
